 | • レポートコード：QY20ST-02983 • 出版社/出版日：QYResearch / 2020年9月15日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、134ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥560,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥840,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,120,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、世界のRNAワクチン市場について種類別（個別がん治療MRNAワクチン、感染症治療MRNAワクチン、感染予防MRNAワクチン）、用途別（感染症、がん、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・RNAワクチン市場の概要 ・世界の主要地域別RNAワクチン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のRNAワクチン市場規模2015-2026：種類別（個別がん治療MRNAワクチン、感染症治療MRNAワクチン、感染予防MRNAワクチン） ・世界のRNAワクチン市場規模2015-2026：用途別（感染症、がん、その他） ・RNAワクチンの北米市場規模2015-2020 ・RNAワクチンのヨーロッパ市場規模2015-2020 ・RNAワクチンの中国市場規模2015-2020 ・RNAワクチンの日本市場規模2015-2020 ・RNAワクチンの東南アジア市場規模2015-2020 ・RNAワクチンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・RNAワクチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・RNAワクチンの市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global RNA Vaccines Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global RNA Vaccines market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
RNA is a rather versatile technology and offers a number of advantages. RNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes RNA especially attractive for vaccines and gene editing. RNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of RNA has greatly favored the development of in vivo transfection strategies.
RNA Vaccines & Therapeutics is in the development stage and there is no use in the market. The fastest research is Clinical phrase II, such as AGS-004 of Argos Therapeutics, SB-FIX, SB-318, SB-913 of Sangamo Therapeutics. The major application of RNA Vaccines & Therapeutics is for infectious disease, cancer and others. And infectious disease and cancer are the major applications.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the RNA Vaccines market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the RNA Vaccines industry.
Based on our recent survey, we have several different scenarios about the RNA Vaccines YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of RNA Vaccines will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global RNA Vaccines market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global RNA Vaccines market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global RNA Vaccines market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global RNA Vaccines market. The report also includes nautical information, where it shows RNA Vaccines market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global RNA Vaccines market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global RNA Vaccines market.
Geographical Analysis:
Based on region, the global RNA Vaccines market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global RNA Vaccines market are
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
Segment by Type
Individualized Cancer Treatment MRNA Vaccine
Infectious Disease Treatment MRNA Vaccine
Infection Prevention MRNA Vaccine
Segment by Application
Infectious Disease
Cancer
Other
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global RNA Vaccines market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global RNA Vaccines market.
• The market share of the global RNA Vaccines market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global RNA Vaccines market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global RNA Vaccines market.
1 RNA Vaccines Market Overview
1.1 RNA Vaccines Product Scope
1.2 RNA Vaccines Segment by Type
1.2.1 Global RNA Vaccines Sales by Type (2020-2026)
1.2.2 Individualized Cancer Treatment MRNA Vaccine
1.2.3 Infectious Disease Treatment MRNA Vaccine
1.2.4 Infection Prevention MRNA Vaccine
1.3 RNA Vaccines Segment by Application
1.3.1 Global RNA Vaccines Sales Comparison by Application (2020-2026)
1.3.2 Infectious Disease
1.3.3 Cancer
1.3.4 Other
1.4 RNA Vaccines Market Estimates and Forecasts (2015-2026)
1.4.1 Global RNA Vaccines Sales Growth Rate (2015-2026)
1.4.2 Global RNA Vaccines Revenue and Growth Rate (2015-2026)
1.4.3 Global RNA Vaccines Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): RNA Vaccines Industry Impact
1.5.1 How the Covid-19 is Affecting the RNA Vaccines Industry
1.5.1.1 RNA Vaccines Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and RNA Vaccines Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for RNA Vaccines Players to Combat Covid-19 Impact
2 RNA Vaccines Estimate and Forecast by Region
2.1 Global RNA Vaccines Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global RNA Vaccines Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global RNA Vaccines Sales Market Share by Region (2015-2020)
2.2.2 Global RNA Vaccines Revenue Market Share by Region (2015-2020)
2.3 Global RNA Vaccines Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global RNA Vaccines Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global RNA Vaccines Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States RNA Vaccines Estimates and Projections (2015-2026)
2.4.2 Europe RNA Vaccines Estimates and Projections (2015-2026)
2.4.3 China RNA Vaccines Estimates and Projections (2015-2026)
2.4.4 Japan RNA Vaccines Estimates and Projections (2015-2026)
2.4.5 Southeast Asia RNA Vaccines Estimates and Projections (2015-2026)
2.4.6 India RNA Vaccines Estimates and Projections (2015-2026)
3 Global RNA Vaccines Competition Landscape by Players
3.1 Global Top RNA Vaccines Players by Sales (2015-2020)
3.2 Global Top RNA Vaccines Players by Revenue (2015-2020)
3.3 Global RNA Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in RNA Vaccines as of 2019)
3.4 Global RNA Vaccines Average Price by Company (2015-2020)
3.5 Manufacturers RNA Vaccines Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key RNA Vaccines Players (Opinion Leaders)
4 Global RNA Vaccines Market Size by Type
4.1 Global RNA Vaccines Historic Market Review by Type (2015-2020)
4.1.1 Global RNA Vaccines Sales Market Share by Type (2015-2020)
4.1.2 Global RNA Vaccines Revenue Market Share by Type (2015-2020)
4.1.3 Global RNA Vaccines Price by Type (2014-2020)
4.2 Global RNA Vaccines Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global RNA Vaccines Sales Forecast by Type (2021-2026)
4.2.2 Global RNA Vaccines Revenue Forecast by Type (2021-2026)
4.2.3 Global RNA Vaccines Price Forecast by Type (2021-2026)
5 Global RNA Vaccines Market Size by Application
5.1 Global RNA Vaccines Historic Market Review by Application (2015-2020)
5.1.1 Global RNA Vaccines Sales Market Share by Application (2015-2020)
5.1.2 Global RNA Vaccines Revenue Market Share by Application (2015-2020)
5.1.3 Global RNA Vaccines Price by Application (2015-2020)
5.2 Global RNA Vaccines Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global RNA Vaccines Sales Forecast by Application (2021-2026)
5.2.2 Global RNA Vaccines Revenue Forecast by Application (2021-2026)
5.2.3 Global RNA Vaccines Price Forecast by Application (2021-2026)
3 North America RNA Vaccines Market Facts & Figures
3.2 North America RNA Vaccines Sales Market Share by Company (2015-2020)
3.3 North America RNA Vaccines Sales Market Share by Type (2015-2020)
3.4 North America RNA Vaccines Sales Market Share by Application (2015-2020)
4 Europe RNA Vaccines Market Facts & Figures
4.2 Europe RNA Vaccines Sales Market Share by Company (2015-2020)
4.3 Europe RNA Vaccines Sales Market Share by Type (2015-2020)
4.4 Europe RNA Vaccines Sales Market Share by Application (2015-2020)
5 China RNA Vaccines Market Facts & Figures
5.2 China RNA Vaccines Sales Market Share by Company (2015-2020)
5.3 China RNA Vaccines Sales Market Share by Type (2015-2020)
5.4 China RNA Vaccines Sales Market Share by Application (2015-2020)
6 Japan RNA Vaccines Market Facts & Figures
6.2 Japan RNA Vaccines Sales Market Share by Company (2015-2020)
6.3 Japan RNA Vaccines Sales Market Share by Type (2015-2020)
6.4 Japan RNA Vaccines Sales Market Share by Application (2015-2020)
7 Southeast Asia RNA Vaccines Market Facts & Figures
7.2 Southeast Asia RNA Vaccines Sales Market Share by Company (2015-2020)
7.3 Southeast Asia RNA Vaccines Sales Market Share by Type (2015-2020)
7.4 Southeast Asia RNA Vaccines Sales Market Share by Application (2015-2020)
8 India RNA Vaccines Market Facts & Figures
8.2 India RNA Vaccines Sales Market Share by Company (2015-2020)
8.3 India RNA Vaccines Sales Market Share by Type (2015-2020)
8.4 India RNA Vaccines Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in RNA Vaccines Business
12.1 Moderna Therapeutics
12.1.1 Moderna Therapeutics RNA Vaccines Corporation Information
12.1.2 Moderna Therapeutics RNA Vaccines Business Overview and Total Revenue
12.1.3 Moderna Therapeutics RNA Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Moderna Therapeutics RNA Vaccines Products Offered
12.1.5 Moderna Therapeutics Recent Development
12.2 CureVac
12.2.1 CureVac RNA Vaccines Corporation Information
12.2.2 CureVac RNA Vaccines Business Overview and Total Revenue
12.2.3 CureVac RNA Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.2.4 CureVac RNA Vaccines Products Offered
12.2.5 CureVac Recent Development
12.3 Translate Bio
12.3.1 Translate Bio RNA Vaccines Corporation Information
12.3.2 Translate Bio RNA Vaccines Business Overview and Total Revenue
12.3.3 Translate Bio RNA Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Translate Bio RNA Vaccines Products Offered
12.3.5 Translate Bio Recent Development
12.4 BioNTech
12.4.1 BioNTech RNA Vaccines Corporation Information
12.4.2 BioNTech RNA Vaccines Business Overview and Total Revenue
12.4.3 BioNTech RNA Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.4.4 BioNTech RNA Vaccines Products Offered
12.4.5 BioNTech Recent Development
12.5 Sangamo Therapeutics
12.5.1 Sangamo Therapeutics RNA Vaccines Corporation Information
12.5.2 Sangamo Therapeutics RNA Vaccines Business Overview and Total Revenue
12.5.3 Sangamo Therapeutics RNA Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Sangamo Therapeutics RNA Vaccines Products Offered
12.5.5 Sangamo Therapeutics Recent Development
12.6 Argos Therapeutics
12.6.1 Argos Therapeutics RNA Vaccines Corporation Information
12.6.2 Argos Therapeutics RNA Vaccines Business Overview and Total Revenue
12.6.3 Argos Therapeutics RNA Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Argos Therapeutics RNA Vaccines Products Offered
12.6.5 Argos Therapeutics Recent Development
12.7 In-Cell-Art
12.7.1 In-Cell-Art RNA Vaccines Corporation Information
12.7.2 In-Cell-Art RNA Vaccines Business Overview and Total Revenue
12.7.3 In-Cell-Art RNA Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.7.4 In-Cell-Art RNA Vaccines Products Offered
12.7.5 In-Cell-Art Recent Development
12.8 eTheRNA
12.8.1 eTheRNA RNA Vaccines Corporation Information
12.8.2 eTheRNA RNA Vaccines Business Overview and Total Revenue
12.8.3 eTheRNA RNA Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.8.4 eTheRNA RNA Vaccines Products Offered
12.8.5 eTheRNA Recent Development
12.9 Ethris
12.9.1 Ethris RNA Vaccines Corporation Information
12.9.2 Ethris RNA Vaccines Business Overview and Total Revenue
12.9.3 Ethris RNA Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Ethris RNA Vaccines Products Offered
12.9.5 Ethris Recent Development
12.10 Tiba Biotechnology
12.10.1 Tiba Biotechnology RNA Vaccines Corporation Information
12.10.2 Tiba Biotechnology RNA Vaccines Business Overview and Total Revenue
12.10.3 Tiba Biotechnology RNA Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Tiba Biotechnology RNA Vaccines Products Offered
12.10.5 Tiba Biotechnology Recent Development
13 RNA Vaccines Manufacturing Cost Analysis
13.1 RNA Vaccines Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of RNA Vaccines
13.4 RNA Vaccines Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 RNA Vaccines Distributors List
14.3 RNA Vaccines Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global RNA Vaccines Sales (K Doses) Growth Rate by Type (2020-2026)
Table 2. Global RNA Vaccines Sales (K Doses) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four RNA Vaccines Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for RNA Vaccines Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for RNA Vaccines Players to Combat Covid-19 Impact
Table 8. Global Market RNA Vaccines Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global RNA Vaccines Sales (K Doses) by Region (2015-2020)
Table 10. Global RNA Vaccines Sales Market Share by Region (2015-2020)
Table 11. Global RNA Vaccines Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global RNA Vaccines Revenue Share by Region (2015-2020)
Table 13. Global RNA Vaccines Sales (K Doses) Forecast by Region (2021-2026)
Table 14. Global RNA Vaccines Sales Market Share Forecast by Region (2021-2026)
Table 15. Global RNA Vaccines Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global RNA Vaccines Revenue Share Forecast by Region (2021-2026)
Table 17. Global RNA Vaccines (K Doses) of Key Companies (2015-2020)
Table 18. Global RNA Vaccines Sales Share by Company (2015-2020)
Table 19. Global RNA Vaccines Revenue (US$ Million) by Company (2015-2020)
Table 20. Global RNA Vaccines Revenue Share by Company (2015-2020)
Table 21. Global RNA Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in RNA Vaccines as of 2019)
Table 22. Global RNA Vaccines Average Price (USD/Dose) of Key Company (2015-2020)
Table 23. Manufacturers RNA Vaccines Manufacturing Sites and Area Served
Table 24. Manufacturers RNA Vaccines Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key RNA Vaccines Players
Table 27. Global RNA Vaccines Sales (K Doses) by Type (2015-2020)
Table 28. Global RNA Vaccines Sales Share by Type (2015-2020)
Table 29. Global RNA Vaccines Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global RNA Vaccines Price (K Doses) by Type (2015-2020)
Table 31. Global RNA Vaccines Sales Share by Type (2021-2026)
Table 32. Global RNA Vaccines Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global RNA Vaccines Revenue Share by Type (2021-2026)
Table 34. Global RNA Vaccines Price (K Doses) by Type (2021-2026)
Table 35. Global RNA Vaccines Sales (K Doses) by Application (2015-2020)
Table 36. Global RNA Vaccines Sales Share by Application (2015-2020)
Table 37. Global RNA Vaccines Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global RNA Vaccines Price (K Doses) by Application (2015-2020)
Table 39. Global RNA Vaccines Sales (K Doses) by Application (2021-2026)
Table 40. Global RNA Vaccines Sales Share by Application (2021-2026)
Table 41. Global RNA Vaccines Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global RNA Vaccines Revenue Share by Application (2021-2026)
Table 43. Global RNA Vaccines Price (K Doses) by Application (2021-2026)
Table 44. United States RNA Vaccines Sales (K Doses) by Company (2015-2020)
Table 45. United States RNA Vaccines Sales Market Share by Company (2015-2020)
Table 46. United States RNA Vaccines Sales (K Doses) by Type (2015-2020)
Table 47. United States RNA Vaccines Sales Market Share by Type (2015-2020)
Table 48. United States RNA Vaccines Sales (K Doses) by Application (2015-2020)
Table 49. United States RNA Vaccines Sales Market Share by Application (2015-2020)
Table 50. Europe RNA Vaccines Sales (K Doses) by Company (2015-2020)
Table 51. Europe RNA Vaccines Sales Market Share by Company (2015-2020)
Table 52. Europe RNA Vaccines Sales (K Doses) by Type (2015-2020)
Table 53. Europe RNA Vaccines Sales Market Share by Type (2015-2020)
Table 54. Europe RNA Vaccines Sales (K Doses) by Application (2015-2020)
Table 55. Europe RNA Vaccines Sales Market Share by Type (2015-2020)
Table 56. China RNA Vaccines Sales (K Doses) by Company (2015-2020)
Table 57. China RNA Vaccines Sales Market Share by Company (2015-2020)
Table 58. China RNA Vaccines Sales (K Doses) by Type (2015-2020)
Table 59. China RNA Vaccines Sales Market Share by Type (2015-2020)
Table 60. China RNA Vaccines Sales (K Doses) by Application (2015-2020)
Table 61. China RNA Vaccines Sales Market Share by Application (2015-2020)
Table 62. Japan RNA Vaccines Sales (K Doses) by Company (2015-2020)
Table 63. Japan RNA Vaccines Sales Market Share by Company (2015-2020)
Table 64. Japan RNA Vaccines Sales (K Doses) by Type (2015-2020)
Table 65. Japan RNA Vaccines Sales Market Share by Type (2015-2020)
Table 66. Japan RNA Vaccines Sales (K Doses) by Application (2015-2020)
Table 67. Japan RNA Vaccines Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia RNA Vaccines Sales (K Doses) by Company (2015-2020)
Table 69. Southeast Asia RNA Vaccines Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia RNA Vaccines Sales (K Doses) by Type (2015-2020)
Table 71. Southeast Asia RNA Vaccines Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia RNA Vaccines Sales (K Doses) by Type (2015-2020)
Table 73. Southeast Asia RNA Vaccines Sales Market Share by Application (2015-2020)
Table 74. India RNA Vaccines Sales (K Doses) by Company (2015-2020)
Table 75. India RNA Vaccines Sales Market Share by Company (2015-2020)
Table 76. India RNA Vaccines Sales (K Doses) by Type (2015-2020)
Table 77. India RNA Vaccines Sales Market Share by Type (2015-2020)
Table 78. India RNA Vaccines Sales (K Doses) by Application (2015-2020)
Table 79. India RNA Vaccines Sales Market Share by Application (2015-2020)
Table 80. Moderna Therapeutics Corporation Information
Table 81. Moderna Therapeutics Description and Business Overview
Table 82. Moderna Therapeutics RNA Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 83. Moderna Therapeutics RNA Vaccines Product
Table 84. Moderna Therapeutics Recent Development
Table 85. CureVac Corporation Information
Table 86. CureVac Description and Business Overview
Table 87. CureVac RNA Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 88. CureVac RNA Vaccines Product
Table 89. CureVac Recent Development
Table 90. Translate Bio Corporation Information
Table 91. Translate Bio Description and Business Overview
Table 92. Translate Bio RNA Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 93. Translate Bio RNA Vaccines Product
Table 94. Translate Bio Recent Development
Table 95. BioNTech Corporation Information
Table 96. BioNTech Description and Business Overview
Table 97. BioNTech RNA Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 98. BioNTech RNA Vaccines Product
Table 99. BioNTech Recent Development
Table 100. Sangamo Therapeutics Corporation Information
Table 101. Sangamo Therapeutics Description and Business Overview
Table 102. Sangamo Therapeutics RNA Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 103. Sangamo Therapeutics RNA Vaccines Product
Table 104. Sangamo Therapeutics Recent Development
Table 105. Argos Therapeutics Corporation Information
Table 106. Argos Therapeutics Description and Business Overview
Table 107. Argos Therapeutics RNA Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 108. Argos Therapeutics RNA Vaccines Product
Table 109. Argos Therapeutics Recent Development
Table 110. In-Cell-Art Corporation Information
Table 111. In-Cell-Art Description and Business Overview
Table 112. In-Cell-Art RNA Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 113. In-Cell-Art RNA Vaccines Product
Table 114. In-Cell-Art Recent Development
Table 115. eTheRNA Corporation Information
Table 116. eTheRNA RNA Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 117. eTheRNA Description and Business Overview
Table 118. eTheRNA RNA Vaccines Product
Table 119. eTheRNA Recent Development
Table 120. Ethris Corporation Information
Table 121. Ethris RNA Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 122. Ethris Description and Business Overview
Table 123. Ethris RNA Vaccines Product
Table 124. Ethris Recent Development
Table . Tiba Biotechnology Corporation Information
Table . Tiba Biotechnology Description and Business Overview
Table . Tiba Biotechnology RNA Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table . Tiba Biotechnology RNA Vaccines Product
Table . Tiba Biotechnology Recent Development
Table 130. Production Base and Market Concentration Rate of Raw Material
Table 131. Key Suppliers of Raw Materials
Table 132. RNA Vaccines Distributors List
Table 133. RNA Vaccines Customers List
Table 134. Market Key Trends
Table 135. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 136. Key Challenges
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. RNA Vaccines Product Picture
Figure 2. Global RNA Vaccines Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global RNA Vaccines Market Share by Application in 2020 & 2026
Figure 6. Infectious Disease Examples
Figure 7. Cancer Examples
Figure 8. Other Examples
Figure 9. Global RNA Vaccines Sales (K Doses) Growth Rate (2015-2026)
Figure 10. Global RNA Vaccines Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global RNA Vaccines Price Trends Growth Rate (2015-2026) (USD/Dose)
Figure 12. Global RNA Vaccines Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global RNA Vaccines Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States RNA Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States RNA Vaccines Sales (K Doses) Growth Rate (2015-2026)
Figure 16. Europe RNA Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe RNA Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China RNA Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China RNA Vaccines Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan RNA Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan RNA Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia RNA Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia RNA Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India RNA Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India RNA Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest RNA Vaccines Players Market Share by Revenue in RNA Vaccines 2015 & 2019
Figure 27. RNA Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global RNA Vaccines Revenue Share by Type (2015-2020)
Figure 29. Global RNA Vaccines Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global RNA Vaccines Revenue Share by Application (2015-2020)
Figure 31. Global RNA Vaccines Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States RNA Vaccines Sales Market Share by Type in 2019
Figure 33. United States RNA Vaccines Sales Market Share by Type in 2019
Figure 34. Europe RNA Vaccines Sales Market Share by Company in 2019
Figure 35. Europe RNA Vaccines Sales Market Share by Type in 2019
Figure 36. Europe RNA Vaccines Sales Market Share by Application in 2019
Figure 37. China RNA Vaccines Sales Market Share by Company in 2019
Figure 38. China RNA Vaccines Sales Market Share by Type in 2019
Figure 39. China RNA Vaccines Sales Market Share by Application in 2019
Figure 40. Japan RNA Vaccines Sales Market Share by Company in 2019
Figure 41. Japan RNA Vaccines Sales Market Share by Type in 2019
Figure 42. Japan RNA Vaccines Sales Market Share by Application in 2019
Figure 43. Southeast Asia RNA Vaccines Sales Market Share by Company in 2019
Figure 44. Southeast Asia RNA Vaccines Sales Market Share by Type in 2019
Figure 45. Southeast Asia RNA Vaccines Sales Market Share by Application in 2019
Figure 46. India RNA Vaccines Sales Market Share by Company in 2019
Figure 47. India RNA Vaccines Sales Market Share by Type in 2019
Figure 48. India RNA Vaccines Sales Market Share by Application in 2019
Figure 49. Moderna Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. CureVac Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Translate Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. BioNTech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Sangamo Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Argos Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. In-Cell-Art Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. eTheRNA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Ethris Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Tiba Biotechnology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Key Raw Materials Price Trend
Figure 60. Manufacturing Cost Structure of RNA Vaccines
Figure 61. Manufacturing Process Analysis of RNA Vaccines
Figure 62. RNA Vaccines Industrial Chain Analysis
Figure 63. Channels of Distribution
Figure 64. Distributors Profiles
Figure 65. Porter's Five Forces Analysis
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
mRNAワクチン及び治療薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The mRNA Vaccines & Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…- mRNAワクチン及び治療薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The mRNA Vaccines & Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…
- mRNA癌ワクチン及び治療剤の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The mRNA Cancer Vaccines and Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value cha…
- mRNA癌ワクチン及び治療剤の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The mRNA Cancer Vaccines and Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value cha…
- 子宮頸がんワクチンの世界市場レポート2020 Cervical cancer vaccines can effectively prevent cervical cancer in women due to human papillomavirus, and the best age for cervical cancer vaccine injection is 15 years old.Depending on the immunity to the under-15s and over-15s, the cervical cancer vaccine has only a 0.2 per cent chance of develop…